Metabolomic Signatures of Alzheimer’s Disease Indicate Brain Region-Specific Neurodegenerative Progression
International Journal of Molecular Sciences · 30.09.2023 · 24 (19) · 14769
DOI: 10.3390/ijms241914769 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.09.2023. Verfasst von Mirela Ambeskovic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Canadian Centre for Behavioural Neuroscience, Department of Neuroscience, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Alberta Innovates, Alberta Innovates fellowship.
Themen: Demenz
Abstract (Originalsprache)
Pathological mechanisms contributing to Alzheimer’s disease (AD) are still elusive. Here, we identified the metabolic signatures of AD in human post-mortem brains. Using 1H NMR spectroscopy and an untargeted metabolomics approach, we identified (1) metabolomic profiles of AD and age-matched healthy subjects in post-mortem brain tissue, and (2) region-common and region-unique metabolome alterations and biochemical pathways across eight brain regions revealed that BA9 was the most affected. Phenylalanine and phosphorylcholine were mainly downregulated, suggesting altered neurotransmitter synthesis. N-acetylaspartate and GABA were upregulated in most regions, suggesting higher inhibitory activity in neural circuits. Other region-common metabolic pathways indicated impaired mitochondrial function and energy metabolism, while region-unique pathways indicated oxidative stress and altered immune responses. Importantly, AD caused metabolic changes in brain regions with less well-documented pathological alterations that suggest degenerative progression. The findings provide a new understanding of the biochemical mechanisms of AD and guide biomarker discovery for personalized risk prediction and diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Canadian Centre for Behavioural Neuroscience, Department of Neuroscience, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.
- Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
- Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.
- Southern Alberta Genome Sciences Centre, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.
ORCID-Profile: Tony Montina, Gerlinde A S Metz
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Alberta Innovates
- Alberta Innovates fellowship
Zitieren
APA
Ambeskovic, M., Hopkins, G., Hoover, T., Joseph, J. T., Montina, T., & Metz, G. A. S. (2023). Metabolomic Signatures of Alzheimer’s Disease Indicate Brain Region-Specific Neurodegenerative Progression. International Journal of Molecular Sciences, 24(19), 14769. https://doi.org/10.3390/ijms241914769
Vancouver
Ambeskovic M, Hopkins G, Hoover T, Joseph JT, Montina T, Metz GAS. Metabolomic Signatures of Alzheimer’s Disease Indicate Brain Region-Specific Neurodegenerative Progression. International Journal of Molecular Sciences. 2023;24(19):14769. doi:10.3390/ijms241914769
BibTeX
@article{Ambeskovic2023,
author = {Ambeskovic, Mirela and Hopkins, Giselle and Hoover, Tanzi and Joseph, Jeffrey T and Montina, Tony and Metz, Gerlinde A S},
title = {Metabolomic Signatures of Alzheimer’s Disease Indicate Brain Region-Specific Neurodegenerative Progression},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {19},
pages = {14769},
doi = {10.3390/ijms241914769}
}
EUVIMED